Imatib 400mg Imatinib Tablet

Imatib 400mg Imatinib Tablet is a prescription targeted anti-cancer medication used in the treatment of chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), gastrointestinal stromal tumors (GISTs), and certain other cancers. It contains Imatinib, a tyrosine kinase inhibitor (TKI) that works by blocking abnormal proteins responsible for the growth and multiplication of cancer cells. By targeting these specific cellular pathways, Imatib 400mg Imatinib Tablet helps slow disease progression and supports long-term cancer management. Taken orally under the supervision of an oncology specialist, it requires regular monitoring to assess treatment response and manage potential side effects. Patients should use Imatib 400mg Imatinib Tablet only as prescribed by their healthcare provider and attend all scheduled follow-up appointments during treatment.